Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 28, 2013; 19(8): 1158-1165
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1158
From fatty liver to fibrosis: A tale of “second hit”
Metin Basaranoglu, Gökcen Basaranoglu, Hakan Sentürk
Metin Basaranoglu, Hakan Sentürk, Gastroenterology and Hepatology, Bezmialem Vakif University, Istanbul 34400, Turkey
Gökcen Basaranoglu, Department of Anaesthesiology, Bezmialem Vakif University, Istanbul 34400, Turkey
Author contributions: Basaranoglu M contributed extensively to the work, performed the literature search and designed and wrote the paper; Sentürk H and Basaranoglu G commented on the paper.
Correspondence to: Metin Basaranoglu, MD, Gastroenterology and Hepatology, Bezmialem Vakif University, Istanbul 34400, Turkey. metin_basaranoglu@yahoo.com
Telephone: +90-312-5878030 Fax: +90-312-5540570
Received: April 5, 2012
Revised: June 13, 2012
Accepted: June 28, 2012
Published online: February 28, 2013
Abstract

Although much is known about how fat accumulates in the liver, much remains unknown about how this causes sustained hepatocellular injury. The consequences of injury are recognized as nonalcoholic steatohepatitis (NASH) and progressive fibrosis. The accumulation of fat within the hepatocytes sensitizes the liver to injury from a variety of causes and the regenerative capacity of a fatty liver is impaired. An additional stressor is sometimes referred to as a “second hit” in a paradigm that identifies the accumulation of fat as the “first hit”. Possible candidates for the second hit include increased oxidative stress, lipid peroxidation and release of toxic products such as malondialdehyde and 4-hydroxynonenal, decreased antioxidants, adipocytokines, transforming growth factor (TGF)-β, Fas ligand, mitochondrial dysfunction, fatty acid oxidation by CYPs (CYP 2E1, 4A10 and 4A14), and peroxisomes, excess iron, small intestinal bacterial overgrowth, and the generation of gut-derived toxins such as lipopolysaccharide and ethanol. Oxidative stress is one of the most popular proposed mechanisms of hepatocellular injury. Previous studies have specifically observed increased plasma and tissue levels of oxidative stress markers and lipid peroxidation products, with reduced hepatic and plasma levels of antioxidants. There is also some indirect evidence of the benefit of antioxidants such as vitamin E, S-adenosylmethionine, betaine, phlebotomy to remove iron, and N-acetylcysteine in NASH. However, a causal relationship or a pathogenic link between NASH and oxidative stress has not been established so far. A number of sources of increased reactive oxygen species production have been established in NASH that include proinflammatory cytokines such as tumor necrosis factor (TNF)-α, iron overload, overburdened and dysfunctional mitochondria, CYPs, and peroxisomes. Briefly, the pathogenesis of NASH is multifactorial and excess intracellular fatty acids, oxidant stress, ATP depletion, and mitochondrial dysfunction are important causes of hepatocellular injury in the steatotic liver.

Keywords: Fatty liver; Oxidative stress; Fibrosis; Nonalcoholic fatty liver diseases; Nonalcoholic steatohepatitis